Physician profile
Ellen Neu
NPI 1942465000
$1,451.91
in general payments reported to CMS, 2019-2025
17 companies · $959 in 2025
The $959 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.16 · 2022: $18.09 · 2023: $23.41 · 2024: $439 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.51 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $218.78 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $167.57 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $156.71 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Scilex Pharmaceuticals INC. | $92.68 | 2023-2024 | Ztlido |
| Forte Bio-Pharma LLC | $61.89 | 2024 | Prolate, Nalocet |
| Pfizer INC. | $57.35 | 2024 | |
| Amgen INC. | $52.05 | 2022-2025 | Krystexxa |
| Lilly USA, LLC | $51.19 | 2025 | Mounjaro, Zepbound |
| Mylan Specialty L.P. | $36.89 | 2024 | Yupelri |
| Sumitomo Pharma America, INC. | $25.03 | 2025 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $21.34 | 2024 | Ajovy |
| Grifols USA, LLC | $20.04 | 2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $18.69 | 2024 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $17.81 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shield Therapeutics INC | $14.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Neu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.